Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseStem CellsMyeloablative AgonistsHematopoietic Stem CellsBusulfanTreatment OutcomeGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineCord Blood Stem Cell TransplantationIfosfamideSalvage TherapyHematopoiesisVincristineAmyloidosisCytarabineDisease-Free SurvivalTransplantation ChimeraHodgkin DiseaseTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellDoxorubicinPlatelet CountBlood Cell CountTransplantation, IsogeneicPOEMS SyndromePrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteLeukemiaDexamethasoneVidarabineFollow-Up StudiesRecombinant ProteinsAntineoplastic AgentsBone Marrow PurgingEmbryonic Stem CellsBlood CellsProspective StudiesLymphomaCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAdult Stem CellsMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationImmunophenotypingLymphocyte DepletionAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesBlood Transfusion, AutologousT-LymphocytesHLA AntigensLiver TransplantationBone MarrowBlood DonorsFlow CytometryLeukocytes, MononuclearCell SeparationPluripotent Stem CellsOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-Lymphoma